{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03759431",
            "orgStudyIdInfo": {
                "id": "18.135"
            },
            "organization": {
                "fullName": "Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM)",
                "class": "OTHER"
            },
            "briefTitle": "Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer",
            "officialTitle": "A Randomized Study of Vocal-cord Only vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer",
            "acronym": "VOCAL",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "vocal-cord-vs-complete-laryngeal-radiotherapy-for-early-glottic-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-10-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-11-10",
            "studyFirstSubmitQcDate": "2018-11-28",
            "studyFirstPostDateStruct": {
                "date": "2018-11-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-11",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM)",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "London Health Sciences Centre",
                    "class": "OTHER"
                },
                {
                    "name": "M.D. Anderson Cancer Center",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multicentrer, randomized Bayesian Phase II trial for patients with early stage (T1N0) glottic squamous cell carcinoma treated with radical radiotherapy. The primary objective is to assess the non-inferiority of local control achieved with vocal-cord only radiotherapy (VC-RT) compared to complete larynx radiotherapy (CL-RT) in T1N0 glottic laryngeal squamous cell cancer, measured at 2-years after treatment. Secondary outcomes include overall survival, as well as voice impairment, dysphagia and quality of life, measured respectively by the voice handicap index -10 (VHI-10), the MD Anderson Dysphagia Inventory (MDADI) and the MD Anderson Symptom Inventory- Head and Neck module (MDASI-HN). Patients will be randomized in a 1:3 ratio to CL-RT (39 patients) and VC-RT (116 patients) arms. There will be stratification by tumor stage (T1a/T1b) and by institution. An interim analysis is planned after the first 55 patients enrolled on the experimental arm have a 6-month follow-up."
        },
        "conditionsModule": {
            "conditions": [
                "Cancer Neck",
                "Larynx Cancer",
                "Glottis Tumor"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 155,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Vocal-cord Radiotherapy",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Radiation: Vocal-cord Radiotherapy"
                    ]
                },
                {
                    "label": "Complete Larynx Radiotherapy",
                    "type": "ACTIVE_COMPARATOR",
                    "interventionNames": [
                        "Radiation: Complete Larynx Radiotherapy"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "RADIATION",
                    "name": "Vocal-cord Radiotherapy",
                    "description": "Focal radiotherapy limited to the involved vocal cord(s) plus additional margins accounting for respiration and set-up errors.",
                    "armGroupLabels": [
                        "Vocal-cord Radiotherapy"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Complete Larynx Radiotherapy",
                    "description": "Radiotherapy to the entire larynx, with target volumes defined to lead to traditional volumes from conventional complete larynx radiotherapy.",
                    "armGroupLabels": [
                        "Complete Larynx Radiotherapy"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Local control",
                    "description": "Local control rate of vocal-cord radiotherapy",
                    "timeFrame": "At 2-year follow-up"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Voice Handicap Index-10 score",
                    "description": "Scores are rated on a 0-4 scale to indicate the presence and severity of the symptoms. Lower scores represent better functioning and quality of life.",
                    "timeFrame": "Week 0 post-treatment, and at 2-month, 6-month, 1-year and 2-year follow-up"
                },
                {
                    "measure": "MD Anderson Dysphagia Inventory score",
                    "description": "Overall score ranges from 0 to 100, with higher score representing better functioning and quality of life.",
                    "timeFrame": "Week 0 post-treatment, and at 2-month, 6-month, 1-year and 2-year follow-up"
                },
                {
                    "measure": "MD Anderson Symptom Inventory-Head & Neck score",
                    "description": "The core and head and neck cancer specific symptoms are rated on a 0-10 scale to indicate the presence and severity of the symptoms. Lower scores represent better functioning and quality of life.",
                    "timeFrame": "Week 0 post-treatment, and at 2-month, 6-month, 1-year and 2-year follow-up"
                },
                {
                    "measure": "Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V)",
                    "description": "The attributes of CAPE-V are: (a) Overall Severity; (b) Roughness; (c) Breathiness; (d) Strain; (e) Pitch; and (f) Loudness. Each attribute is displayed accompanied by a 100- millimeter line forming a visual analog scale, with a higher score representing more deviant voice attributes.",
                    "timeFrame": "Week 0 post-treatment and at 6-month follow-up"
                },
                {
                    "measure": "Rates of acute toxicity as per CTCAE v5.0",
                    "timeFrame": "Week 0 post-treatment and at 2-month follow-up"
                },
                {
                    "measure": "Rates of chronic toxicity as per CTCAE v5.0",
                    "timeFrame": "At 6-month, 1-year, 2-year and 5-year post-treatment"
                },
                {
                    "measure": "Rates of new hypothyroidism",
                    "timeFrame": "At 2- and 5-year follow-up"
                },
                {
                    "measure": "Rates of cerebrovascular event (transient ischemic attack or stroke)",
                    "timeFrame": "At 5-year follow-up"
                },
                {
                    "measure": "Overall survival",
                    "timeFrame": "At 2- and 5-year follow-up"
                },
                {
                    "measure": "Time to recurrence",
                    "timeFrame": "At 2- and 5-year follow-up"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Stage T1a-b N0 of the true vocal cords planned for definitive RT\n* Patient not candidate for laser surgery or declined laser surgery\n* Biopsy-confirmed squamous cell carcinoma, including verrucous carcinoma\n* Eastern Cooperative Oncology Group performance status 0-2\n* Ability to provide written informed consent.\n\nExclusion Criteria:\n\n* Previous irradiation of the head and neck (HNC) region\n* Pregnancy or breastfeeding\n* Any medical condition that represents, in the opinion of the investigator, a contraindication to radiotherapy or would prevent follow-up after radiotherapy.\n* Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 2 years.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Diane Trudel",
                    "role": "CONTACT",
                    "phone": "514-890-8000",
                    "phoneExt": "11181",
                    "email": "diane.dt.trudel.chum@ssss.gouv.qc.ca"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Houda Bahig",
                    "affiliation": "Centre hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM)",
                    "role": "STUDY_CHAIR"
                },
                {
                    "name": "David Palma",
                    "affiliation": "London Health Sciences Centre",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "The University of Texas MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Victoria Cox",
                            "role": "CONTACT",
                            "phone": "877-832-6789",
                            "email": "vcox@mdanderson.org"
                        },
                        {
                            "name": "David I Rosenthal",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Clifton D Fuller",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "London Health Sciences Centre",
                    "status": "RECRUITING",
                    "city": "London",
                    "state": "Ontario",
                    "zip": "N6A 5W9",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Patricia Moore",
                            "role": "CONTACT",
                            "phone": "519-685-8500",
                            "email": "patricia.moore@lhc.on.ca"
                        },
                        {
                            "name": "David Palma",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.98339,
                        "lon": -81.23304
                    }
                },
                {
                    "facility": "Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al",
                    "status": "RECRUITING",
                    "city": "Montreal",
                    "state": "Quebec",
                    "zip": "H2X 1R6",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Diane Trudel",
                            "role": "CONTACT",
                            "phone": "514-890-8000",
                            "phoneExt": "26906",
                            "email": "diane.dt.trudel.chum@ssss.gouv.qc.ca"
                        },
                        {
                            "name": "Houda Bahig",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Phuc-F\u00e9lix Nguyen-Tan",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "33888069",
                    "type": "DERIVED",
                    "citation": "Bahig H, Rosenthal DI, Nguyen-Tan FP, Fuller DC, Yuan Y, Hutcheson KA, Christopoulos A, Nichols AC, Fung K, Ballivy O, Filion E, Ng SP, Lambert L, Dorth J, Hu KS, Palma D. Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial. BMC Cancer. 2021 Apr 22;21(1):446. doi: 10.1186/s12885-021-08195-8."
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007822",
                    "term": "Laryngeal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010039",
                    "term": "Otorhinolaryngologic Neoplasms"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000007818",
                    "term": "Laryngeal Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000010038",
                    "term": "Otorhinolaryngologic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10835",
                    "name": "Laryngeal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10839",
                    "name": "Laryngeal Neoplasms",
                    "asFound": "Larynx Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12962",
                    "name": "Otorhinolaryngologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12961",
                    "name": "Otorhinolaryngologic Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC09",
                    "name": "Ear, Nose, and Throat Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                }
            ]
        }
    },
    "hasResults": false
}